david miklos, md, discusses the outcomes in the phase 2 ibrutinib study for chronic gvhd
Published 7 years ago • 286 plays • Length 3:27
Download video MP4
Download video MP3
Similar videos
-
1:51
david miklos, md, phd, explains how ibrutinib is being studied for the treatment of gvhd
-
9:28
david miklos, md, phd: ibrutinib in chronic graft-versus-host disease
-
1:44
david miklos, md, phd, describes the optimal way to use ibrutinib in the treatment of gvhd
-
4:33
integrate: 2-year follow-up of ibrutinib plus corticosteroids for cgvhd
-
7:27
ibrutinib to treat chronic graft versus host disease
-
10:59
good news!! if diagnosed with ddd (degenerative disc disease) must know this!!
-
57:41
inflammatory cardiomyopathies/myocarditis (rayan yousefzai, md & guests) may 13, 2021
-
10:00
how to engage anomalous coronary artery
-
13:34
allogeneic transplants & graft-versus-host disease (gvhd) | dr. david miklos, stanford
-
21:21
clinical impact of h-y alloimmunization by david miklos, md, phd
-
9:14
cvi 2019_thursday, 7/18_ coronary challenging case competition _david aguilar, md
-
1:39
robert soiffer, md, discusses ways to enhance the activity of il-2 in chronic gvhd
-
1:01
david j. mcconkey, phd, on treating bladder cancer with checkpoint inhibitors
-
2:06
bruce d. cheson, md, discusses care, toxicities, and outcomes treating cll patients with venetoclax
-
5:31
cvi2017 challenging case - mohamad kabach, md (case 2)
-
1:08
real-world use of subcutaneous d-vtd in transplant-eligible patients with newly diagnosed myeloma
-
3:45
cvi2017 challenging case - konstantinos charitakis, md
-
15:55
clinical considerations in switching antiretroviral therapy | david jilich, md
-
0:54
evaluating the potential for nivolumab to extend survival in non-metastatic mibc
-
5:28
david j. andorski: a discussion about the magnify trial
-
10:33
cvi2017 challenging case - konstantinos marmagkiolis, md
-
1:41
david fajgenbaum, md, mba, msc: important tests in multicentric castleman disease
Clip.africa.com - Privacy-policy